组织多普勒成像技术评价老年高血压患者右心室功能的临床研究

目的探讨组织多普勒成像(TDI)技术评价老年高血压患者右心室功能的临床价值。方法选择老年高血压患者34例(高血压组)和健康老年人44例(对照组)。经胸超声心动图检查,应用TDI技术于心尖四腔观获取右心室侧壁三尖瓣环处心肌运动频谱图,测量舒张早期峰值速度(Em)、舒张晚期峰值速度(Am),并计算Em和Am比值。同时测量收缩期峰值速度(Sm)、等容收缩期心肌加速度。结果高血压组Em(5.91±1.56)cm/s、Am(12.79±2.63)cm/s、Sm(10.82±1.45)cm/s均明显低于对照组Em(7.57±2.11)cm/s、Am(14.27±2.03)cm/s、Sm(12.68±2.33)cm/s,差异有统计学意义(P=0.000,P=0.006,P=0.000);Em/Am高血压组(0.47±0.12)明显低于对照组(0.54±0.15),差异有统计学意义(P=0.048)。结论 TDI可以准确、直观地评价老年高血压患者右心室功能。     

Tissue Doppler imaging and the quantification of myocardial function

Tissue Doppler imaging (TDI) has recently been introduced in clinical echocardiography. Most widely used are tissue velocity maps, in which the velocity of moving tissue is calculated relative to the transducer from the Doppler shift and displayed as colour-encoded velocity maps in either M-mode or two-dimensional image formats (Doppler velocity mode). This allows detection and quantification of dyssynergic areas of the myocardium. Additionally, the velocities may be studied with pulsed wave-tissue Doppler sampling (PW-TDS) which displays the velocity of a selected myocardial region versus time with high temporal resolution. Less often used, are tissue acceleration maps which display acceleration or velocity change of subsequent frames as different colours (Doppler acceleration mode). These maps may find application in clinical electrophysiology. Another TDI modality is tissue energy imaging, which is based on the integration of the power spectrum of the Doppler signals from the tissue. This technique provides maps of Doppler energy which are represented as colour brightness. Such maps offer potential for the study of myocardial perfusion. TDI modalities have promise to become clinically useful for quantifying myocardial function.     

Tissue Doppler imaging for the evaluation of patients with hypertrophic cardiomyopathy

PURPOSE OF REVIEW: To discuss the role of tissue Doppler imaging for assessing regional myocardial function in patients with proven or suspected hypertrophic cardiomyopathy and review its application in clinical practice for diagnosis, estimation of filling pressures, and monitoring of treatment. RECENT FINDINGS: Patients with hypertrophic cardiomyopathy have very abnormal systolic and diastolic myocardial function, even if global systolic function of the left ventricle appears normal. Regional function is most abnormal in walls that are markedly hypertrophied, but it is also abnormal in segments that are not affected by hypertrophy, and it is depressed in patients who have a mutation for hypertrophic cardiomyopathy but have not yet developed clear phenotypic changes. Genetic diagnosis remains difficult especially in sporadic cases, due to the very large number of mutations that have been identified; the hypertrophy may represent a nonspecific compensatory response to any mutation that impairs myofibrillar function. Subclinical changes especially affect long-axis ventricular function, and tissue Doppler imaging is the most sensitive test to identify reduced velocities of long-axis shortening and early diastolic lengthening of the left ventricle, prolonged contraction and relaxation times, and reduced strain in affected segments, both in patients with hypertrophy and in asymptomatic subjects with mutations. It can also discriminate well between hypertrophic cardiomyopathy and athlete's heart, and can be used with standard echocardiographic measurements to estimate left ventricular filling pressure or to monitor treatment. SUMMARY: Tissue Doppler imaging can now be usefully incorporated into the routine echocardiographic study of patients with proven or suspected hypertrophic cardiomyopathy.     

Tissue Doppler imaging in the evaluation of patients with cardiac amyloidosis

PURPOSE OF REVIEW: Although two-dimensional, M-mode, and Doppler echocardiography have played a major role in the assessment of amyloid deposition in the heart, diagnosis of cardiac amyloidosis (CA) based on these conventional techniques is often only possible once the disease is in a relatively advanced stage. To optimize survival, early diagnosis and institution of therapy are essential. Recently, tissue Doppler imaging (TDI) and myocardial strain rate (SR) have emerged as important clinical tools in the assessment of CA. RECENT FINDINGS: Tissue Doppler imaging-derived modalities including TDI velocities, strain, and SR are currently being used in the early diagnosis and evaluation of patients with CA. Although these new indices have been examined in relatively few patients, findings suggest an important and expanding role of TDI in amyloid infiltration of the heart. SUMMARY: This review summarizes the recent literature addressing the role of TDI velocities, strain, and SR in the diagnosis and assessment of CA.     

Comparison of left ventricular function by tissue Doppler imaging in patients with diabetes mellitus without systemic hypertension versus diabetes mellitus with systemic hypertension

Because diabetes mellitus substantially increases the risk of development of heart failure, we sought to establish early alterations in left ventricular systolic and diastolic function in patients with diabetes mellitus with and without coexisting systemic hypertension. We studied 134 subjects using echocardiography comprising standard 2-dimensional and conventional Doppler as well as tissue Doppler imaging. Our study demonstrated the early appearance of both left ventricular systolic and diastolic dysfunction in diabetic patients at rest and the contributory effects of diabetes to myocardial impairment produced by hypertension, as well as the high usefulness of tissue Doppler imaging in detection and quantitation of myocardial dysfunction in diabetics. This method was superior to other echocardiographic techniques and plasma brain natriuretic peptide evaluation.     

Doppler echocardiographic evaluation of left ventricular diastolic function in adolescents with diabetes mellitus

Doppler echocardiograms of the mitral valve were recorded along with electrocardiograms and respirations from 20 diabetics and 16 normal subjects, all aged 10 to 15 years. E and A areas (the components of the total velocity-time integral in the early passive period of ventricular filling [E] and the late active period of atrial emptying [A], respectively), the peak E and A velocities (cm/s) and the 1/3 area fraction (or the proportion of filling in the first 1/3 of diastole) were measured. Each of the following was significantly greater for the normal subjects versus diabetic patients: peak E (96 +/- 14 vs 81 +/- 14 cm/s, p less than 0.005), E/total area (0.74 +/- 0.04 vs 0.69 +/- 0.06, p less than 0.005) and peak E/A velocity ratio (2.38 +/- 0.55 vs 1.92 +/- 0.55, p less than 0.05). The mean heart rates and ages were not significantly different for the 2 groups. The remaining parameters (peak A velocity, A/total area, E/A area, and 1/3 area fraction) were also not significantly different for the 2 groups. This study is the first to demonstrate diastolic dysfunction in pediatric patients with diabetes and may indicate abnormalities of ventricular relaxation or compliance in diabetes mellitus.     

Tissue Doppler imaging in the evaluation of left ventricular diastolic function

PURPOSE OF REVIEW: Describe the rationale behind, and clinical use of, tissue Doppler (TD) imaging in the assessment of left ventricular (LV) diastolic function, with a focus on recent developments. RECENT FINDINGS: Tissue Doppler imaging is a novel echocardiographic technique that directly measures myocardial velocities. Systolic TD measurements assess left and right ventricular myocardial contractile function. Diastolic TD values reflect myocardial relaxation, and in combination with conventional Doppler measurements, ratios (E/Ea) have been developed to estimate LV filling pressures. TD values and derived ratios have been demonstrated to be valuable in the diagnosis of elevated LV filling pressures, clinical congestive heart failure (CHF), and the prognosis of patients with cardiac disease and CHF. New TD indices have now been developed to assess myocardial relaxation and LV filling pressures, and the impact of LV systolic function on the use of TD imaging has recently been described. TD echocardiography is being used in an ever-widening group of patients for the assessment of LV diastolic function, and its correlation to, and comparison with, B-type natriuretic peptide is an active area of current investigation. SUMMARY: This review focuses on new developments in the clinical use of TD echocardiography in the evaluation of left ventricular diastolic function.     

组织多普勒成像对正常成人左、右心功能对比观测

目的:探讨组织多普勒成像(tissue Doppler imaging,TDI)技术对正常成人左、右心功能的对比评价。方法:健康成人300例根据年龄分为6组,经胸超声心动图检查,采用心尖四腔切面,应用TDI技术,将取样点置于左室侧壁二尖瓣瓣环处及右室侧壁三尖瓣瓣环处,记录心肌运动速度频谱,测量收缩期峰值(Vs)、舒张早期运动速度峰值(Ve)、舒张晚期运动速度峰值(Va)及Ve/Va比值。结果:二、三尖瓣环处Ve/Va与年龄呈负相关(r1=-0.946,P0.01及r2=-0.925,P0.01),Vs值与年龄不相关;随着年龄增加,舒张早期Ve逐渐减低,Va逐渐增高,二者比值逐渐出现倒置,尤其三尖瓣瓣环出现更早,50岁左右出现,而二尖瓣环处比值倒置在60岁以后。结论:随着年龄增长舒张功能逐渐减低,并且右心室舒张功能减低早于左心室,收缩功能与年龄不相关。     

多普勒组织成像与脉冲多普勒方法对比评价高血压患者舒张功能

目的应用脉冲多普勒组织成像测量二尖瓣环平均舒张速度,以鉴别高血压患者舒张功能假性正常。方法在健康者(正常组200例)与高血压患者(高血压组47例)中,应用脉冲多普勒技术分别测量二尖瓣口舒张早期峰值速度(E)、舒张晚期峰值速度(A),肺静脉收缩波(S)、舒张波(D)及心房收缩波(Ar)。应用脉冲多普勒组织成像测量二尖瓣环各点舒张早期峰值速率(Ea)、舒张晚期峰值速率(Aa)。结果正常组与对照组患者二尖瓣E、A、E/A差异无显著性意义,肺静脉S、S/D、Ar差异有显著性意义,二尖瓣环平均Ea间差异有显著性意义,Aa间差异无显著性意义。结论二尖瓣环舒张早期速率可用于鉴别高血压舒张功能假性正常。     

Tissue Doppler imaging identifies myocardial dysfunction in adults with Marfan syndrome

BACKGROUND: Successful prevention of aortic complications has lead to improved survival of Marfan syndrome (MFS). With increasing age, however, ventricular arrhythmia and heart failure are emerging as life-threatening manifestations of myocardial dysfunction. HYPOTHESIS: We sought to investigate whether echocardiography with tissue Doppler imaging (TDI) identifies myocardial dysfunction in adults with MFS. METHODS: We performed two-dimensional (2-D) and Doppler echocardiography with TDI in 141 individuals with suspected MFS and competent heart valves, including 28 persons with MFS who had not undergone surgery and 86 healthy controls without inherited connective tissue disorders. RESULTS: Demographic profile, 2-D, mitral and pulmonary venous flow indices, and left ventricular ejection fractions were similar in both groups. Conversely, isovolumic relaxation time (p < 0.001) and deceleration time of E velocity (p = 0.005) were longer, and atrial reversal velocities (p = 0.02), and systolic and early diastolic TD velocities were slower in MFS than in controls (p = 0.01). Multiple linear regression analysis excluded association of reduced systolic and early diastolic TD velocities with mitral valve prolapse or other clinical or echocardiographic features of MFS. CONCLUSIONS: Our study identifies reduced systolic and early diastolic TD velocities in adults with MFS. Further studies are mandatory to elucidate whether TD velocities predict arrhythmia and heart failure in MFS.     

Lung function in patients with diabetes mellitus

Lung function was assessed in 35 nonsmoking adults with insulin dependent diabetes mellitus and 34 matched control subjects. The tests included spirometry, lung volumes, CO transfer factor and maximum respiratory pressures. Additionally, in subjects under 35 years of age (20 patients and 18 controls) measurements of CO transfer factor were obtained during exercise at three different workloads. Random blood glucose and glycosylated haemoglobin were measured and each patient's diabetic history was recorded. The total lung capacity (TLC) in the patients was lower than those recorded for the controls (P less than 0.05) but there were no significant differences in respiratory muscle strength between the groups. In the young group of patients (less than 35 years) the transfer factor for CO (TLCO) was similar but the volume corrected transfer coefficient (KCO) was higher at rest than in the controls (P less than 0.02). The KCO remained high in these patients during exercise. The older patients (greater than 35 years) showed a lower TLCO (P less than 0.01) with a similar KCO to the controls. The association of a reduction in TLC and higher KCO in the young patients suggests an extrapulmonary mechanism of lung volume restriction. This is not attributable to muscle weakness but might be due to limited expansion of the rib cage. In older patients any tendency for KCO to rise may be masked by disease-related changes in the pulmonary microvasculature.     

Pulmonary function in patients with diabetes mellitus

BACKGROUND: Pulmonary complications of diabetes mellitus have been poorly characterized. Although some authors have reported normal pulmonary function, others found abnormalities in lung volumes, pulmonary mechanics, and diffusing capacity. SUBJECTS AND METHODS: We studied pulmonary function in a group of patients with diabetes using a combined cardiopulmonary exercise test. Twenty-seven patients with diabetes aged 48 +/- 13 years participated in the study. RESULTS: Overall, forced vital capacity, forced expiratory volume in 1 second, and forced expiratory flow, midexpiratory phase, were within the predicted values, but the residual volume/total lung capacity ratio was slightly elevated. Comparison by diabetes type showed nonsignificant differences in forced expiratory volume in 1 second and forced expiratory flow, midexpiratory phase. Residual volume/total lung capacity ratio was significantly elevated in type 1 patients compared with type 2. Carbon monoxide diffusion capacity (DLCO) was normal in both groups. There was no correlation between the results on pulmonary function test and duration of disease, presence of microangiopathy, or glycemic control. The DLCO was significantly lower in patients with microangiopathic changes, but not when DLCO was corrected for alveolar volume. On the cardiopulmonary exercise test, maximal workload, maximum oxygen uptake, and maximal heart rate were less than predicted, whereas anaerobic threshold and ventilatory reserve were normal. No significant differences were noted in diabetes type, and there was no correlation between parameters of cardiopulmonary exercise test and the other variables. CONCLUSION: Spirometric values are preserved in patients with diabetes mellitus, and there are no defects in diffusing capacity. Cardiovascular factors may account for impaired physical performance. There is no need for routine screening of pulmonary function among diabetic patients.     

Tissue Doppler imaging for predicting outcome in patients with cardiovascular disease

PURPOSE OF REVIEW: Tissue Doppler imaging is being increasingly used for assessing global ventricular function in systole and diastole, and for quantifying regional wall motion abnormalities both in systolic heart failure with mechanical dyssynchrony and ischemic heart disease. Its use as a predictive tool is recent and the authors review publications relating to this aspect. RECENT FINDINGS: Peak early diastolic mitral annular velocity is a powerful predictor of outcome in a variety of cardiovascular conditions and adds incremental value to clinical parameters and standard mitral Doppler inflow velocities. Tissue Doppler imaging can also predict the development of hypertrophic cardiomyopathy in asymptomatic individuals carrying the genetic mutation even before the onset of overt left ventricular hypertrophy. In addition, the standard deviation of the time to peak systolic velocity is a good marker of mechanical asynchrony and can predict reverse remodeling. It may also be useful in identifying individuals with ischemic heart disease and regional wall motion abnormalities who have an adverse outcome. SUMMARY: Tissue Doppler imaging is a powerful new echocardiographic tool that is now becoming the standard for assessing ventricular function in a variety of situations and diseases.     

核素肾动态显像对2型糖尿病患者肾功能的研究

目的 了解不同阶段２型糖尿病（ＤＭ）患者肾脏血流动力学的变化及肾功能受损情况。方法 将５７例２型ＤＭ患者根据尿白蛋白排泄率（ＵＡＥＲ）分为三组：（１）ＤＭ正常白蛋白尿组（ＤＭ１组）１１例,ＵＡＥＲ〈２０ｕｇ／ｍｉｎ。（２）ＤＭ微量白蛋白尿组（ＤＭ２组）２６例,ＵＡＥＲ：２０～２００ｕｇ／ｍｉｎ。（３）ＤＭ临床蛋白尿组（ＤＭ３组）２０例,ＵＡＥＲ〉２００ｕｇ／ｍｉｎ。与２０例正常对照组（ＮＣ）一起进     

Tissue Doppler imaging in the evaluation of the regional diastolic function in chagas' disease.

AIMS: The main purpose of this study was to evaluate the regional diastolic function in Chagas' disease using tissue Doppler imaging (TDI). METHODS AND RESULTS: Seventy-seven patients were evaluated and divided into three groups: group 0, control; group 1, chagasic patients with normal ECG; and group 2, chagasic patients with abnormal ECG. The following parameters were evaluated: E and A waves, E/A ratio, deceleration time and the isovolumic relaxation time by pulsed wave Doppler and analysis of early (e') and late (a') filling waves by means of TDI, in basal segment of the septal, anterior, inferior, posterior and lateral walls of the left ventricle. The only index of the transmitral flow that presented a significant difference between the chagasic patients and the controls was the deceleration time. As regards the TDI, a significant difference occurred between the various groups in relation to the e' wave, especially in the septal, inferior and posterior walls of the left ventricle. CONCLUSION: TDI proved itself a more sensitive technique for the study of the diastolic function in Chagas' disease than conventional Doppler echocardiography, bringing to light regional abnormalities and allowing differentiation between normal and chagasic individuals with or without cardiomyopathy. TDI could be potentially useful in clinical work and in the stratification of risk of these patients.     

Mortality after myocardial infarction in patients with diabetes mellitus

See article on page 1577Diabetes mellitus (diabetes), in particular type 2 diabetes, constitutes one of the largest emerging threats to health in the 21st century. It is estimated that by 2030 as many as 360 million people world wide will be affected.¹The cause of death in those with diabetes is dominated by coronary heart disease, accompanied by increased rates of stroke and peripheral vascular disease: so called macrovascular complications. At least two‐thirds of deaths are attributable to these cardiovascular diseases and their sequelae.² A true picture of the extent of macrovascular complications is obscured, however, by inaccurate death certification³ and diagnostic criteria⁴ based on the development of microvascular complications (retinopathy, neuropathy, nephropathy). The Euro Heart⁵ Survey demonstrated that if one applied oral glucose tolerance tests to those presenting with all forms of acute coronary syndrome, two‐thirds display impaired glucose regulation.In the USA, although the overall mortality rate associated with coronary heart disease has declined over the past 20 years, this trend has not been reflected in a decline of mortality rates in patients with diabetes.⁶ Results published in this issue of Heart from the Swedish registry on coronary care (RIKS‐HIA) confirm this trend (see article on page 1577).⁷ After a myocardial infarction (MI), patients with diabetes had an increased mortality rate compared with non‐diabetic patients. Moreover, despite the existence of treatments which may benefit diabetic patients disproportionately, the relative hazard of mortality in diabetic patients has improved little compared with non‐diabetic patients between the time periods 1995–8 and 1999–2002. These observations give us a glimpse of the vast epidemic that is approaching, if not upon us.